New Advancements in FDA Approved Successful Hair Loss Treatments

The only non-governmental organization recognized by the FDA as knowledgeable on the subject of alopecia (hair loss) is the American Hair Loss Association. This organization carries out education, research and demonstrates a constant commitment to education the public on matters of alopecia for men and women.

It is interesting to note that the American Hair Loss Association and the FDA both advise the public not to purchase any treatments unless the FDA specifically approves them. Any medication approved by the FDA will be clearly marked on packaging of the approved product.

The scientific name for hair loss is alopecia, which literally means hair loss. There are many causes or reasons for hair loss and the word alopecia applies to all of them. Recent articles by major American news organizations have reported that just in America the expenditure of funds on various hair loss treatments exceeds 3.5 billion U.S. dollars every year.

In addition to the sale of worthless “snake oil” medications, an industry promising success using some non-medicinal processes has also improperly thrived at the same time. According to the FDA, only one surgical possibility not based on treatment by medication is as follows. If there is a close enough genetic match between donor and recipient, or if enough hair, of the right type, is present on the back of the recipients own head some success can be seen with surgical transplant.

Some other advertised procedures consistently fail to mention the necessity for genetically matched hair is the key to the processes they promote. In other words, they also do not work as advertised.

To complicate matters even more, the hair loss treatments, recently discovered and approved by the FDA, are not the same for male and female victims of alopecia.

Women cannot safely utilize treatments recently approved for men. Changes of hormonal balance resulting from use of the approved medication are the reason.

The reason there is now an approved treatment for alopecia in men is purely coincidental. Side effects observed during drug testing for treatment of other male medical problems indicated possible advancements in hair loss treatments.

Development proceeded on an alopecia specific version of the drug as soon as FDA approval for use in men was in hand. This cut the development and testing time by nearly 80 percent. Without the coincidental observation of hair growth during testing for other reasons, development for alopecia would never have occurred.

The non-brand generic name for the FDA approved drug to treat alopecia is Finasteride. It was during FDA approval testing for this drug that unexpected hair growth appeared. This drug is only available by prescription under a patent protected brand name for the effective treatment of alopecia, specifically male pattern baldness.

The exciting news about this break through treatment for hair loss is the following. More than 86 percent of men taking this pill form medication experienced a stop in hair loss. Even better is the result that more than 65 percent of men in test trials not only had hair loss come to a stop, they had significant increase in the growth of new hair.

For men not experiencing a stop in hair loss using Finasteride there is another medication to try. The non-brand generic name of this medication is Loniten, which actually received FDA approval before Finasteride. For the men that have success with Finasteride, this drug does not work. Medical trials with Loniten did show limited success for men that had little or no success using Finasteride.

So medical science has finally given many men hope in controlling hair loss. Early diagnosis of alopecia is the key to receiving the most success in treating hair loss of the male pattern baldness type.

True Your Hair offers professional hair loss treatments for men and women. Featuring the latest techniques, discover their services today.